SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-151214
Filing Date
2021-12-17
Accepted
2021-12-17 17:02:35
Documents
1
Period of Report
2021-12-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2135659-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2135659-3_4seq1.xml 4 4701
  Complete submission text file 0001104659-21-151214.txt   6484
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS INC. 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address
Almenoff June Sherie (Reporting) CIK: 0001492647 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36641 | Film No.: 211502424